| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Connect Biopharma Holdings Ltd
13G
CNTB · 207523101
|
9.6% |
4/14/2026
Event 4/14/2026
|
|||
| BioFortune Inc | 9.5% | ||||
| Wubin Pan | 9.6% | ||||
|
Connect Biopharma Holdings Ltd
13G/A
Amendment 3
CNTB · 207523101
|
10.8% |
2/17/2026
Event 12/31/2025
|
|||
| BioFortune Inc. | 10.7% | ||||
| Wubin Pan | 10.8% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.